New fertility drug combo aims to boost IVF success, but trial halted early
NCT ID NCT06466486
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 31 times
Summary
This early-stage study tested whether adding the drug FE999302 to standard fertility treatment (follitropin delta) could improve the number of high-quality embryos in women undergoing ovarian stimulation for IVF. The trial enrolled about 310 women aged 18-40 with normal ovarian reserve. The study was terminated early, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FERTILITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ferring Investigational Site
Brussels, 1090, Belgium
-
Ferring Investigational Site
Edegem, 2650, Belgium
-
Ferring Investigational Site
Prague, Prague, 150 00, Czechia
-
Ferring Investigational Site
Prague, 160 00, Czechia
-
Ferring Investigational Site
Prague, 184 00, Czechia
-
Ferring Investigational Site
Hvidovre, Hvidovre, 2650, Denmark
-
Ferring Investigational Site
Copenhagen, 2100, Denmark
-
Ferring Investigational Site
Trondheim, Sor-Trondelag, 7042, Norway
-
Ferring Investigational Site
Bergen, 5006, Norway
-
Ferring Investigational Site
Porsgrunn, 3913, Norway
-
Ferring Investigational Site
Madrid, Aravaca, 28023, Spain
-
Ferring Investigational Site
Barcelona, 08028, Spain
-
Ferring Investigational Site
Madrid, 28010, Spain
-
Ferring Investigational Site
Seville, 41092, Spain
-
Ferring Investigational Site
Valencia, 46015, Spain
Conditions
Explore the condition pages connected to this study.